Clearstead Advisors’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28K Buy
596
+180
+43% +$871 ﹤0.01% 2435
2026
Q1
$2.21K Hold
416
﹤0.01% 1881
2025
Q4
$3.21K Hold
416
﹤0.01% 2091
2025
Q3
$3.67K Sell
416
-193
-32% -$1.44K ﹤0.01% 2271
2025
Q2
$2.53K Buy
609
+193
+46% +$1.21K ﹤0.01% 2276
2025
Q1
$2.51K Hold
416
﹤0.01% 1861
2024
Q4
$2.15K Hold
416
﹤0.01% 1834
2024
Q3
$1.24K Hold
416
﹤0.01% 1891
2024
Q2
$1.24K Buy
+416
New +$3.43K ﹤0.01% 1876

Other funds holding VSTM

Clearstead Advisors's VSTM Position: Q2 2026 in Review

Clearstead Advisors increased its Verastem (VSTM) stake by 43% in Q2 2026, buying an estimated $871 and bringing the position to 596 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

Clearstead Advisors first reported a position in VSTM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.67K in Q3 2025. 43 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Clearstead Advisors held 596 shares of Verastem worth $2.28K as of Q2 2026.
  • Clearstead Advisors bought 180 Verastem shares in Q2 2026, an estimated $871.
  • Verastem made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2435 holding.
  • Clearstead Advisors first reported a position in Verastem in Q2 2024 and has held it in 9 quarters since.
  • Clearstead Advisors's Verastem position peaked at $3.67K in Q3 2025.
  • 43 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.